Evidence map›Paper›PMID 39058980›Full record

ReviewRetinal cases & brief reports2025

SEVERE CIRCULATORY DISTURBANCE IN OPTIC DISK, RETINA, AND CHOROID AFTER SUB-TENON TRIAMCINOLONE ACETONIDE INJECTION FOR POSTERIOR SCLERITIS.

Masahiro Akada, Yuki Muraoka, Satoshi Morooka, Kenji Ishihara, Masayuki Hata, Akitaka Tsujikawa

Abstract readCase ReportsReview
In one paragraph

Review in Retinal cases & brief reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Masahiro AkadaDepartment of Ophthalmology and Visual Sciences, Kyoto University Graduate School of Medicine, Kyoto, Japan.
Satoshi Morooka
Kenji Ishihara
Masayuki Hata
Akitaka Tsujikawa

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeTo report a rare case of optic disk and chorioretinal vascular occlusions in the right eye after sub-Tenon injection of triamcinolone acetonide (STTA) in an older male patient with scleritis and to discuss the associated risk factors and potential alternative therapies.

methodsThe medical history and clinical examination, including fundoscopy, fluorescein angiography (FA), and indocyanine green angiography (ICGA), were conducted to diagnose and evaluate the extent of vascular occlusion after STTA. An extensive literature review was undertaken to ascertain the associated risks and consider other treatment options for scleritis.

resultsSevere circulatory disturbances in the optic disk and chorioretinal regions of the right eye developed after STTA for exacerbated scleritis, as confirmed by FA and ICGA, resulting in a significant decrease in visual acuity. A complex medical history encompassing ophthalmic and systemic health issues may have contributed to this negative outcome. A literature review pointed out the potential complications of STTA and highlighted alternative approaches to scleritis management.

conclusionCautious application of STTA in treating scleritis is crucial, especially in patients with preexisting vascular or ocular conditions. Thus, a multidisciplinary approach and a careful assessment of various treatment options are vital to minimize the risk of severe complications and improve patient outcomes.

Indexed as

ChoroidGlucocorticoidsOptic DiskScleritisTriamcinolone AcetonideFluorescein AngiographyHumansInjections, IntraocularMaleVisual AcuityGlucocorticoidsTriamcinolone Acetonidechoroid and retinacirculatory disturbanceoptic diskscleritissub-Tenon injection of triamcinolone acetonide

Identifiers

PMID39058980
PMCPMC12570599

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.